Glycemia in newborns of hypertensive mothers according to maternal treatment
PURPOSE: To evaluate the evolution of glycemic levels in newborns of hypertensive mothers according to maternal treatment. METHODS: Prospective randomized study, including 93 newborns of mothers treated with isradipine (n = 39), atenolol (n = 40), or low sodium diet (control group - n=14). Glycemia was determined at birth (mother and newborn by the oxidase glucose method) and in the 1st, 3rd, 6th, 12th, and 24th hours after birth (newborn by a test strip method). The evolution of glycemia was analyzed in each group (Friedman test). The groups were compared regarding glycemia (Kruskall-Wallis test), and linear regression models were constructed for the analyses (independent variable = maternal glycemia; dependent variables = umbilical cord, 3rd, and 6th hour glycemia). RESULTS: There were no statistically significant differences among the mean blood glucose levels of the 3 groups in any of the assessments. There was a correlation between maternal and umbilical cord blood glucose in the isradipine (r = 0.61; P <.05) and control (r = 0.84; P <.05) groups. Regarding glycemia levels of the mothers and newborns in the third and sixthhours postpartum, this correlation was present only in the control group (maternal x third hour: r = 0.65; P <.05; maternal x sixth hour: r = 0.68; P <.05). There were no correlations in the atenolol group. Hypoglycemia was detected in 51.3% of the isradipine group, 60% of the atenolol group, and 35.7% of the control group, and it was more frequent in the first hour postpartum in all groups. CONCLUSIONS: The results suggest a similar effect of the 3 types of treatment upon newborn glycemia. The correlation analysis suggests that isradipine could have effects upon newborn glycemia only after birth (correlation only in umbilical cord blood), whereas atenolol could act earlier (there was no correlation at any moment). The results also point to the need for glycemic control from the first hour postpartum of newborns of hypertensive mothers whether they have or have not undergone treatment with antihypertensive drugs.
Main Authors: | Darcie,Silvana, Leone,Cléa R., Calil,Valdenise M. L. T., Prescinotti,Elizete P., Kahhale,Soubhi, Zugaib,Marcelo |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Faculdade de Medicina / Universidade de São Paulo - FM/USP
2004
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000500004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maternal mortality due to arterial hypertension in São Paulo City (1995-1999)
by: Vega,Carlos Eduardo Pereira, et al.
Published: (2007) -
Expert recommendations for the care of newborns of mothers with COVID-19
by: Carvalho,Werther Brunow de, et al.
Published: (2020) -
Inflammatory and oxidative stress airway markers in premature newborns of hypertensive mothers
by: Madoglio,R.J., et al.
Published: (2016) -
Hematological disorders in preterm newborns born to mothers with pregnancy-induced hypertension
by: Arce-López,Karina L., et al.
Published: (2022) -
Relationship between maternal and foetal glycemia and foetal endocrine pancreas in alpacas
by: Huaynates O., Johan, et al.
Published: (2016)